期刊文献+

糖化血红蛋白联合血糖测定在高危人群中筛查2型糖尿病的价值及相关性 被引量:5

Glycated hemoglobin combined glucose determination in high-risk groups in screening of type 2 diabetes value and the related
原文传递
导出
摘要 目的:探讨诊断2型糖尿病时糖化血红蛋白(HbA1c)的最佳切点,并对比分析空腹血糖(FPG)和HbA1c对于诊断的敏感性和特异性。方法:117名2型糖尿病高危人群,男67名,女50名,以1999年美国糖尿病学会(ADA)标准为诊断标准,通过绘制受试者工作特征曲线(ROC曲线),分析比较FPG及HbA1c诊断的敏感性和特异性。结果:①HbA1c的ROC曲线的最佳切点为6.45%,灵敏度74.6%,特异性90.1%,曲线下面积0.91(95%CI 0.83-0.95),阳性似然比9.6,阴性似然比0.27,阳性预测值93.0%,阴性预测值70.4%。②FPG ROC曲线的最佳切点为6.45 mmol/L,灵敏度87.3%,特异性85.9%,曲线下面积0.92(95%CI 0.86-0.96),阳性似然比7.0,阴性似然比0.15。③当HbA1c≥6.45%时,诊断的准确性为93.0%,而FPG≥6.45 mmol/L时诊断的准确性为84.1%。结论:HbA1c≥6.45%可作为诊断2型糖尿病的一种可靠方法,且诊断的准确性较FPG高,敏感性较FPG低,若同时联合检测分别以HbA1c 6.45%和FPG6.45 mmol/L切点,诊断DM的敏感性和特异性分别为90.1%和95.8%。 Objective:Explore diagnosed type 2 diabetes glycated hemoglobin(HbA1c) the best non-oil imports,and comparative analysis of fasting plasma glucose(FPG) and HbA1c to the diagnosis of sensitivity and specificity.Methods: 117 in type 2 diabetes high-risk groups,male 67,female 50 to 1999 American diabetes association(ADA) criteria for diagnosis criteria,draw a receiver-operating characteristic curve(ROC curves),analysis and comparison FPG HbA1c diagnosis and the sensitivity and specificity.Results:(1) the best HbA1c the ROC curves for 6.45% non-oil imports,sensitivity and specificity,curve 90.1% 74.6% in the area under 0.91(95% CI 0.83-0.95),positive,negative likelihood ratio 9.6 likelihood ratio,0.27 positie predictie 70.4% 93.0%,negative predictive value.2 the best FPG ROC curves for 6.45 mmol/l non-oil imports 87.3%,specificity and sensitivity,curve 85.9% area under the following CI 0.86-0.92(95%),positive,negative likelihood ratio 7.0 likelihood ratio 0.15.3 when HbA1c p 6.45%,the diagnostic accuracy of 93.0%,and for mmol/l p FPG 6.45 when the diagnostic accuracy of is 84.1%.Conclusion: HbA1c p 6.45% can serve as a diagnosis of type 2 diabetes a reliable method,and the diagnostic accuracy of high sensitivity is relatively FPG FPG low,if also joint test respectively by 45% HbA1c6.FPG6.45 mmol/l and non-oil imports,diagnostic DM sensitivity and specificity 90.1% and localizing respectively.
出处 《中国卫生检验杂志》 CAS 2011年第5期1226-1227,共2页 Chinese Journal of Health Laboratory Technology
关键词 糖化血红蛋白 空腹血糖 糖尿病 葡萄糖耐量试验(OGTT) 受试者工作特征曲线 Glycated hemoglobin Fasting glucose diabetes Glucose tolerance test(OGTT) The receiver-operating characteristic curve
  • 相关文献

参考文献6

  • 1Diabetes Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or mefformin [J]. N Engl J Med, 2002, 346(6) :393 -403.
  • 2TUOMILEHTO J, LINDSTROM J, ERIKSSON JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance [J]. N Engl J Med, 2001,344(18) :1343 - 1350.
  • 3American Diabetes Association. Standards of medical care in diabetes- 2007[J]. Diabetes Care, 2007, 30(1) :S2 -S4.
  • 4DEEPA R, RANI SS, PREMALATHA G, et al. Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians--the Chennai Urban Population Study [ J ]. Am Diabetes Assoc Diabet Med, 2000, 17(12) :872 -874.
  • 5周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:157
  • 6张健,杨青,张进安,陈妤,秦秋,杨婧,闫妮.糖化血红蛋白在高危人群诊断2型糖尿病中的价值[J].西安交通大学学报(医学版),2010,31(4):512-514. 被引量:33

二级参考文献22

  • 1周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:157
  • 2Diabetes Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J]. N Engl J Med, 2002, 346(6)393-403.
  • 3TUOMILEHTO J, LINDSTROM J, ERIKSSON JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance [J]. N Engl J Med, 2001, 344(18):1343-1350.
  • 4American Diabetes Association. Standards of medical care in diabetes-2007EJ3. Diabetes Care, 2007, 30(1).S2-S41.
  • 5The DECODE-Study Group on behalf of European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies[J]. Diabetologia, 1999, 42(6) :647-654.
  • 6DEEPA R, RANI SS, PREMALATHA G, et al. Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians the Chennai Urban Population Study [J].Am Diabetes Assoc Diabet Med, 2000, 17(12):872-874.
  • 7GOMEZ-PEREZ FJ, AGUILAR-SALINAS CA, LOPEZ-ALVARENGA JC, et al. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose [J]. Diabetes Care, 1998, 21(11) . 1886-1888.
  • 8BENNETT CM, GUO M, DHARMAGE SC. HbAlc as a screening tool for detection of type 2 diabetes: a systematic review [J].Diabetic Med, 2007, 24(4) :333-343.
  • 9KIM KS, KIM SK, LEE YK, et al. Short Report: Diagnostic value of glycated haemoglobin (HbAlc) for the early detection of diabetes in high-risk subjects [J]. Diabetic Meal, 2008, 25 (8) :1464-5491.
  • 10KILPATRICK ES, MAYLOR PW, KEEVIL BG. Biological variation of giycated hemoglobin. Implications for diabetes screening and monitoring[J]. Diabetes Care, 1998, 21(2) :261-264.

共引文献181

同被引文献51

  • 1胡晓抒,郭志荣,周慧,史祖民,武鸣,张均,孙国祥,周正元,潘晓群,姚才良.江苏省35~74岁人群代谢综合征的流行病学调查[J].中华流行病学杂志,2006,27(9):751-756. 被引量:110
  • 2American Diabetes Association. Executive summary: standards of medical care in diabetes-2010[J]. Diabe- tes Care,2010,33(suppl 1) :S4-S10.
  • 3Mostafa SA, Khunti K, Srinivasan BT, et al. Detecting Type 2 diabetes and impaired glucose regulation using glycated hemoglobin in different populations[J]. Dia- betes Management, 2011,1 (1) : 77-97.
  • 4McCarter RJ, Gomez R, Hempe JM, et al. Biological variation in HbAlc predicts risk of retinopathy and nephropathy in type 1 diabetes[J]. Diabetes Care, 2004,27 (6), 1259-1264.
  • 5Hempe JM, Gomez R, McCarter RJ, et al. High and low hemoglobin glycation phenotypes in type 1 diabe- tes..a challenge for interpretation of glycemic control [J]. Journal of Diabetes Complications, 2002,16 (5) : 313-320.
  • 6Nathan DM,Turgeon H, Regan S, et al. Relationship between glycated haemoglobin levels and mean glu- cose levels over time[J ]. Diabetologia, 2007,50 ( 11 ) : 2239-2244.
  • 7Nathan DM. Caveats regarding the use of HbAlc for prediction of mean blood glucose. Reply to Chalew S, Hempe JM (letter) [J]. Diabetologia, 2008, 51 (5) : 905-906.
  • 8Alberti KG,Zimmer PZ. Definition,Diagnosis and cla- ssification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes melli- tus provisional report of a WHO eonsultation[J]. Di- abet Med,1998,15(7) :539-553.
  • 9Rohlfing CL, Wiedmeyer HM, Little RR, et al. Defi- ning the relationship between plasma glucose and HbAlc analysis of glucose profiles and HbAlc in the diabetes control and complications trial[J]. Diabetes Care,2002,25(2):275-278.
  • 10Braga F, Dolci A, Montagnana M,et al. Revaluation of biological variation of glyeated hemoglobin (HbAlc) using an accurately designed protocol and an assay traceable to the IFCC reference system[J]. Cliniea Chimica Acta,2011,412(15) : 1412-1416.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部